GAVI

Non-communicable diseases ( NCDs ) are the leading causes of death globally. NCDs killed 36 million people in 2008, representing 63 % of global deaths, principally from cardiovascular diseases, diabetes, cancer and chronic respiratory infections. [German] [French]

Learn about GAVI's involvement in health system strengthening. [French]

If fully funded, GAVI can accelerate access to new vaccines that will save a further four million lives by 2015. [French]

The GAVI Alliance was launched in 2000, at a time when the distribution of vaccines to children in the poorest parts of the world had begun to falter. [French]

GAVI’s health system strengthening support to Ethiopia is US$ 76,494,000 for 2007 to 2009, and CSO support amounts to US $ 3,420,000 over a two year period from 2008 to 2010. The objectives of the GAVI Alliance for CSO support in Ethiopia are to increase immunisation coverage within seven regions, three of which – Somali, Gambella, and Afar –, have the lowest immunisation rates in the country. The focus of the support will be directed to hard-to-reach and marginalised populations.

US$ 5.41 million have been approved by GAVI for CSO support from 2007 to 2010. The grant was channelled through an already established network of non-governmental organisations (NGOs) that then issued subgrants to other NGOs for

implementation. This has resulted in significant achievements within the first year of implementation.

GAVI’s CSO support to Pakistan amounts to US$ 4,587,000 over a two-year period from 2009 to 2010. The GAVI CSO grant provides an opportunity to improve the partnership between CSOs and the government of Pakistan. CSOs have traditionally

worked with the government on an ad hoc basis, with weak linkages and coordination between the two sectors at both the central and lower levels.

The purpose of these case studies is to document experiences and lessons learned under the GAVI CSO grant, including the application and selection process, implementation to date, and monitoring and reporting.

GAVI launched the AVI initiative in January 2009 to facilitate the rapid and large-scale introduction of pneumococcal and rotavirus vaccines in GAVI-eligible countries and to establish a platform for future introduction of other new vaccines. [French]